Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 15 Annual British Thoracic Oncology Group (BTOG) Conference will take place in Dublin, Ireland on 25-27 January, 2017.

BTOG 2017

25–27 January 2017 | Dublin, Ireland

BTOG 2017

25–27 January 2017 | Dublin, Ireland
The 15 Annual British Thoracic Oncology Group (BTOG) Conference will take place in Dublin, Ireland on 25-27 January, 2017.
Going beyond PD-L1 testing for lung cancer immunotherapy 5:02
Going beyond PD-L1 testing for lung cancer immunotherapy
Juergen Wolf • 28 Jan 2017
Repeat biopsy in lung cancer patients with EGFR mutation 3:34
Repeat biopsy in lung cancer patients with EGFR mutation
Neal Navani • 28 Jan 2017
Whole mutational burden as a predictive marker for response to immunotherapy 1:41
Whole mutational burden as a predictive marker for response to immunotherapy
Juergen Wolf • 28 Jan 2017
Balancing the benefits and costs of immunotherapy in the treatment of lung cancer 1:54
Balancing the benefits and costs of immunotherapy in the treatment of lung cancer
Rolf Stahel • 29 Jan 2017
EBUS and CT-guided biopsy in repeat biopsies of patients with progressive lung cancer 2:26
EBUS and CT-guided biopsy in repeat biopsies of patients with progressive lung cancer
Neal Navani • 29 Jan 2017
How to discuss immunotherapy as a treatment option with lung cancer patients 0:45
How to discuss immunotherapy as a treatment option with lung cancer patients
Rolf Stahel • 29 Jan 2017
Early clinical trials of immunotherapy treatment combinations 1:28
Early clinical trials of immunotherapy treatment combinations
Juergen Wolf • 29 Jan 2017
How the AURA3 trial has changed conversations about re-biopsy in second-line lung cancer treatment 1:10
How the AURA3 trial has changed conversations about re-biopsy in second-line lung cancer treatment
Neal Navani • 29 Jan 2017
Expanding the clinical trial portfolio for lung cancer 0:53
Expanding the clinical trial portfolio for lung cancer
Matthew Hatton • 29 Jan 2017
What is cancer supportive care? 2:07
What is cancer supportive care?
Sam Ahmedzai • 9 Jun 2017
The evolution of cancer supportive care 1:34
The evolution of cancer supportive care
Sam Ahmedzai • 9 Jun 2017
How to integrate supportive care in oncology? 1:28
How to integrate supportive care in oncology?
Sam Ahmedzai • 9 Jun 2017
Clinical factors in the selection of patients for first-line immunotherapy of lung cancer 2:43
Clinical factors in the selection of patients for first-line immunotherapy of lung cancer
Benjamin Besse • 27 Jan 2017
PD-L1 testing in first-line treatment of NSCLC 1:44
PD-L1 testing in first-line treatment of NSCLC
Benjamin Besse • 28 Jan 2017
Immunotherapy in second-line treatment of non-small cell lung cancer 1:30
Immunotherapy in second-line treatment of non-small cell lung cancer
Benjamin Besse • 28 Jan 2017

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals